查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611906

3D 细胞培养市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

3D Cell Culture Market by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture), Application (Cancer, Drug Discovery, Stem Cell Research), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年3D细胞培养市场规模为19亿美元，预计2024年将达20.4亿美元，复合年增长率为7.63%，2030年将达31.9亿美元。

在类似活体的环境中培养活细胞的创新技术对于生物医学研究的进步至关重要。与传统的 2D 培养相比，它能够在药物发现、癌症研究和组织工程方面提供更准确的预测资料，从而满足了其需求。 3D细胞培养的发展跨越了广泛的领域，包括药物开发、基因研究、再生医学和个人化治疗。最终用途领域包括生物技术、学术机构、医院和诊断实验室。慢性疾病的增加和细胞培养技术的进步是推动市场成长的关键因素。此外，肿瘤学研究中越来越多地采用 3D 培养来研究肿瘤环境也带来了巨大的成长机会。市场上的最新机会包括晶片器官模型和微流体技术的开发，这可以透过提供更可靠和合乎道德的动物测试替代方案来彻底改变药物发现和测试。然而，高成本、技术复杂性和缺乏标准化通讯协定等限制是市场成长的主要障碍。此外，需要专门的人力资源来解释复杂的资料仍然是一个挑战。技术创新的最佳部分包括探索无骨架系统以及整合人工智慧以增强资料分析和预测建模。对新型骨骼生物材料和增强成像技术的研究可能会进一步扩大市场。投资者和公司应专注于与学术机构的策略伙伴关係，以实现尖端创新，并投资可扩展的技术以降低成本。总体而言，3D细胞培养市场的特点是快速发展和创新，市场竞争激烈，需要企业敏捷性和前瞻性策略，以利用新兴趋势并推动成长。能够驾驭复杂情况并提供全面解决方案的公司将处于有利地位，能够充分利用不断扩大的市场机会。

主要市场统计
基准年[2023] 19亿美元
预计年份 [2024] 20.4亿美元
预测年份 [2030] 31.9亿美元
复合年增长率（%） 7.63%

市场动态：揭示快速发展的 3D 细胞培养市场的关键市场洞察

供需的动态交互作用正在改变 3D 细胞培养市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界各地越来越重视再生医学
    • 利用 3D 细胞培养进行抗药性和药物重新定位
    • 增加细胞研发活动及投资
  • 市场限制因素
    • 3D 细胞培养开发所需的高成本和复杂的基础设施
  • 市场机会
    • 3D细胞培养技术的进步支持精准医疗
    • 人们对晶片器官模型的认识与采用不断增强
  • 市场问题
    • 3D 细胞培养的可扩展性有限且缺乏标准化

波特五力：驾驭 3D 细胞培养市场的策略工具

波特的五力架构是了解 3D 细胞培养市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 3D 细胞培养市场的外部影响

外部宏观环境因素在塑造 3D 细胞培养市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解 3D 细胞培养市场的竞争格局

对 3D 细胞培养市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：3D 细胞培养市场供应商绩效评估

FPNV定位矩阵是评估3D细胞培养市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製 3D 细胞培养市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 3D 细胞培养市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 再生医学越来越受到世界各国的关注
      • 利用 3D 细胞培养进行抗药性和药物重新定位
      • 增加细胞研究的研发活动与投资
    • 抑制因素
      • 3D 细胞培养开发成本高且基础设施需求复杂
    • 机会
      • 支持精准医疗的 3D 细胞培养技术的进步
      • 人们对晶片器官模型的认识与采用不断增强
    • 任务
      • 可扩展性有限且 3D 细胞培养非标准化
  • 市场区隔分析
    • 产品：品质优势和功能增加了无支架 3D 细胞培养的采用
    • 应用：增加3D细胞培养在药物发现的应用，以维持药物疗效
    • 最终用户：在实验室采用 3D 细胞培养技术来了解细胞行为
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第 6 章 3D 细胞培养市场：副产品

  • 介绍
  • 3D生物列印
  • 磁浮
  • 基于微流体的 3D 细胞培养
  • 基于支架的 3D 细胞培养
  • 无支架 3D 细胞培养

第 7 章 3D 细胞培养市场：依应用分类

  • 介绍
  • 癌症
  • 药物发现
  • 干细胞研究
  • 组织工程与再生医学
  • 毒理学

第 8 章 3D 细胞培养市场：依最终使用者分类

  • 介绍
  • 製药和生物技术公司
  • 实验室/研究所

第 9 章美洲 3D 细胞培养市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太3D细胞培养市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的3D细胞培养市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Amsbio 宣布 mCollaFibR：3D 细胞培养的创新
    • 富士软片宣布斥资 12 亿美元在北卡罗来纳州扩建，以增强细胞培养能力
    • Molecular Devices 宣布推出 CellXpress.ai 自动化细胞培养系统，这是一个用于快速、可靠药物发现的 3D 生物学创新中心
    • InSphero 和 Advanced BioMatrix 签署分销协议，将 3D 细胞培养应用扩展到基于支架的模型
    • 3D BioFibR 推出两款 CollaFibR 组织工程产品，进军生物列印与 3D 细胞培养市场
  • 战略分析和建议

公司名单

  • 3D BIoTek, LLC
  • Altis Biosystems, Inc.
  • Avantor, Inc.
  • Becton, Dickinson and Company
  • BellBrook Labs
  • Cellink by Bico Group
  • CN Bio Innovations Limited
  • Copner BIoTech
  • Corning Inc.
  • Curesponse Ltd.
  • Electrospinning Company Ltd.
  • Emulate, Inc.
  • Greiner Bio-One International GmbH
  • Hamilton Company
  • InSphero AG
  • JSR Corporation
  • Known Medicine
  • Lonza Group AG
  • MEGAROBO Technologies Co., Ltd.
  • Merck KGaA
  • MIMETAS
  • Ovizio Imaging Systems SA/NV
  • PELOBIOTECH GmbH
  • Promega Corporation
  • PromoCell GmbH
  • Reprocell Inc.
  • SARSTEDT AG & Co. KG
  • Spiderwort Inc.
  • Synthecon Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • TissUse GmbH
  • TreeFrog Therapeutics SAS
Product Code: MRR-43649B5EE3E5

The 3D Cell Culture Market was valued at USD 1.90 billion in 2023, expected to reach USD 2.04 billion in 2024, and is projected to grow at a CAGR of 7.63%, to USD 3.19 billion by 2030.

3D cell culture, an innovative technique for growing biological cells in a way that closely mimics an in vivo environment, is critical for advancing biomedical research. Its necessity is underlined by its ability to provide more accurate predictive data in drug discovery, cancer research, and tissue engineering compared to traditional 2D cultures. Applications of 3D cell culture span pharmaceutical development, genetic studies, regenerative medicine, and personalized therapy. End-use sectors include biotechnology, academic institutions, hospitals, and diagnostic laboratories. The rise of chronic diseases and advancements in cell culture technology are key factors driving market growth. Additionally, the increasing adoption of 3D cultures in oncology research to study tumor environments offers substantial growth opportunities. The latest potential in the market includes developing organ-on-chip models and microfluidics tech that can revolutionize drug discovery and testing by providing more reliable and ethical alternatives to animal testing. However, limitations such as high costs, technical complexity, and lack of standardized protocols present significant barriers to market growth. Moreover, the requirement for specialized personnel to interpret complex data remains a challenge. Best areas of innovation include the exploration of scaffold-free systems and the integration of artificial intelligence to enhance data analysis and predictive modeling. Research into novel biomaterials for scaffolds and enhanced imaging techniques could further expand the market. Investors and companies should focus on strategic partnerships with academic institutions for cutting-edge innovation and invest in scalable technologies to lower costs. Overall, the 3D cell culture market is characterized by rapid evolution and competitive innovation, necessitating agility and forward-thinking strategies for businesses to leverage emerging trends and drive growth. Companies that can navigate the complexities and offer comprehensive solutions will be well-positioned to capitalize on the expanding market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 1.90 billion
Estimated Year [2024] USD 2.04 billion
Forecast Year [2030] USD 3.19 billion
CAGR (%) 7.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Cell Culture Market

The 3D Cell Culture Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing emphasis on regenerative medicine worldwide
    • Adoption of 3D cell culture for drug resistance and drug repositioning
    • Increasing R&D activities and investments in cell-based studies
  • Market Restraints
    • High cost and complex infrastructure requirements for 3D cell culture development
  • Market Opportunities
    • Advancements in 3D cell culture technologies to support precision medicine
    • Emerging awareness and adoption of organ-on-a-chip models
  • Market Challenges
    • Limited scalability and lack of standardization of 3D cell culture

Porter's Five Forces: A Strategic Tool for Navigating the 3D Cell Culture Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Cell Culture Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Cell Culture Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Cell Culture Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Cell Culture Market

A detailed market share analysis in the 3D Cell Culture Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Cell Culture Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Cell Culture Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Cell Culture Market

A strategic analysis of the 3D Cell Culture Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Cell Culture Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek, LLC, Altis Biosystems, Inc., Avantor, Inc., Becton, Dickinson and Company, BellBrook Labs, Cellink by Bico Group, CN Bio Innovations Limited, Copner Biotech, Corning Inc., Curesponse Ltd., Electrospinning Company Ltd., Emulate, Inc., Greiner Bio-One International GmbH, Hamilton Company, InSphero AG, JSR Corporation, Known Medicine, Lonza Group AG, MEGAROBO Technologies Co., Ltd., Merck KGaA, MIMETAS, Ovizio Imaging Systems SA/NV, PELOBIOTECH GmbH, Promega Corporation, PromoCell GmbH, Reprocell Inc., SARSTEDT AG & Co. KG, Spiderwort Inc., Synthecon Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc., TissUse GmbH, and TreeFrog Therapeutics SAS.

Market Segmentation & Coverage

This research report categorizes the 3D Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across 3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture, Scaffold-based 3D Cell Culture, and Scaffold-free 3D Cell Culture.
  • Based on Application, market is studied across Cancer, Drug Discovery, Stem Cell Research, Tissue Engineering & Regenerative Medicine, and Toxicology.
  • Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing emphasis on regenerative medicine worldwide
      • 5.1.1.2. Adoption of 3D cell culture for drug resistance and drug repositioning
      • 5.1.1.3. Increasing R&D activities and investments in cell-based studies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complex infrastructure requirements for 3D cell culture development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in 3D cell culture technologies to support precision medicine
      • 5.1.3.2. Emerging awareness and adoption of organ-on-a-chip models
    • 5.1.4. Challenges
      • 5.1.4.1. Limited scalability and lack of standardization of 3D cell culture
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging adoption of scaffold-free 3D cell culture owing to their qualitative benefits and functionalities
    • 5.2.2. Application: Rising application of 3D cell cultures in drug discovery to maintain drug efficacy
    • 5.2.3. End-User: Adoption of 3D cell culture technology in research labs for understanding cell behavior
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 3D Cell Culture Market, by Product

  • 6.1. Introduction
  • 6.2. 3D Bio Printing
  • 6.3. Magnetic Levitation
  • 6.4. Microfluidics-based 3D Cell Culture
  • 6.5. Scaffold-based 3D Cell Culture
  • 6.6. Scaffold-free 3D Cell Culture

7. 3D Cell Culture Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Drug Discovery
  • 7.4. Stem Cell Research
  • 7.5. Tissue Engineering & Regenerative Medicine
  • 7.6. Toxicology

8. 3D Cell Culture Market, by End-User

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Laboratories & Institutes

9. Americas 3D Cell Culture Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Cell Culture Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Cell Culture Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Amsbio Introduces mCollaFibR: Innovations in 3D Cell Culture
    • 12.3.2. Fujifilm Announces USD 1.2 Billion Expansion in North Carolina for Enhanced Cell Culture Capacities
    • 12.3.3. Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
    • 12.3.4. InSphero and Advanced BioMatrix Signed a Distribution Agreement to Expand the Application Range in 3D Cell Culture Into Scaffold-Based Models
    • 12.3.5. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D Biotek, LLC
  • 2. Altis Biosystems, Inc.
  • 3. Avantor, Inc.
  • 4. Becton, Dickinson and Company
  • 5. BellBrook Labs
  • 6. Cellink by Bico Group
  • 7. CN Bio Innovations Limited
  • 8. Copner Biotech
  • 9. Corning Inc.
  • 10. Curesponse Ltd.
  • 11. Electrospinning Company Ltd.
  • 12. Emulate, Inc.
  • 13. Greiner Bio-One International GmbH
  • 14. Hamilton Company
  • 15. InSphero AG
  • 16. JSR Corporation
  • 17. Known Medicine
  • 18. Lonza Group AG
  • 19. MEGAROBO Technologies Co., Ltd.
  • 20. Merck KGaA
  • 21. MIMETAS
  • 22. Ovizio Imaging Systems SA/NV
  • 23. PELOBIOTECH GmbH
  • 24. Promega Corporation
  • 25. PromoCell GmbH
  • 26. Reprocell Inc.
  • 27. SARSTEDT AG & Co. KG
  • 28. Spiderwort Inc.
  • 29. Synthecon Inc.
  • 30. Tecan Trading AG
  • 31. Thermo Fisher Scientific, Inc.
  • 32. TissUse GmbH
  • 33. TreeFrog Therapeutics SAS

LIST OF FIGURES

  • FIGURE 1. 3D CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. 3D CELL CULTURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. 3D CELL CULTURE MARKET DYNAMICS
  • TABLE 7. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL 3D CELL CULTURE MARKET SIZE, BY 3D BIO PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D CELL CULTURE MARKET SIZE, BY MAGNETIC LEVITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL 3D CELL CULTURE MARKET SIZE, BY MICROFLUIDICS-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-FREE 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL 3D CELL CULTURE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D CELL CULTURE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL 3D CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL 3D CELL CULTURE MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D CELL CULTURE MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023